ID   MRCKA_HUMAN             Reviewed;        1732 AA.
AC   Q5VT25; O75039; Q59GZ1; Q5H9N9; Q5T797; Q5VT26; Q5VT27; Q86XX2;
AC   Q86XX3; Q99646;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   02-NOV-2010, entry version 68.
DE   RecName: Full=Serine/threonine-protein kinase MRCK alpha;
DE            EC=2.7.11.1;
DE   AltName: Full=CDC42-binding protein kinase alpha;
DE   AltName: Full=DMPK-like alpha;
DE   AltName: Full=Myotonic dystrophy kinase-related CDC42-binding kinase alpha;
DE            Short=MRCK alpha;
DE            Short=Myotonic dystrophy protein kinase-like alpha;
GN   Name=CDC42BPA; Synonyms=KIAA0451;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 5), AND FUNCTION.
RC   TISSUE=Colon;
RX   PubMed=15723050; DOI=10.1038/ncb1230;
RA   Wilkinson S., Paterson H.F., Marshall C.J.;
RT   "Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin
RT   phosphorylation and cell invasion.";
RL   Nat. Cell Biol. 7:255-261(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND VARIANT
RP   VAL-1712.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANTS
RP   ILE-1317 AND VAL-1712.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-496, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Mammary gland;
RX   MEDLINE=97248557; PubMed=9092543; DOI=10.1074/jbc.272.15.10013;
RA   Zhao Y., Loyer P., Li H., Valentine V., Kidd V., Kraft A.S.;
RT   "Cloning and chromosomal location of a novel member of the myotonic
RT   dystrophy family of protein kinases.";
RL   J. Biol. Chem. 272:10013-10020(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 799-1732 (ISOFORM 6), AND
RP   VARIANT VAL-1712.
RC   TISSUE=Brain;
RX   MEDLINE=98116662; PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries
RT   from human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [7]
RP   SEQUENCE REVISION.
RA   Ohara O.;
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1521-1644, FUNCTION, INTERACTION WITH
RP   CDC42, AND MUTAGENESIS OF HIS-1579 AND HIS-1582.
RC   TISSUE=Brain;
RX   MEDLINE=98078670; PubMed=9418861;
RA   Leung T., Chen X.-Q., Tan I., Manser E., Lim L.;
RT   "Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a
RT   Cdc42 effector in promoting cytoskeletal reorganization.";
RL   Mol. Cell. Biol. 18:130-140(1998).
RN   [9]
RP   ENZYME REGULATION, OLIGOMERIZATION, PHOSPHORYLATION AT SER-222;
RP   SER-234 AND THR-240, AND MUTAGENESIS OF LYS-106; SER-222; SER-234;
RP   THR-240 AND THR-403.
RX   PubMed=11283256; DOI=10.1128/MCB.21.8.2767-2778.2001;
RA   Tan I., Seow K.T., Lim L., Leung T.;
RT   "Intermolecular and intramolecular interactions regulate catalytic
RT   activity of myotonic dystrophy kinase-related Cdc42-binding kinase
RT   alpha.";
RL   Mol. Cell. Biol. 21:2767-2778(2001).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1545; SER-1719 AND
RP   SER-1721, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1719, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   VARIANTS [LARGE SCALE ANALYSIS] LYS-50; MET-231; THR-537; MET-780;
RP   CYS-790; THR-1148; HIS-1211; ILE-1317; LYS-1418; VAL-1469 AND
RP   ALA-1618.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May act as a downstream effector of CDC42 in
CC       cytoskeletal reorganization. Contributes to the actomyosin
CC       contractility required for cell invasion, through the regulation
CC       of MYPT1 and thus MLC2 phosphorylation.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Maintained in an inactive, closed conformation
CC       by an interaction between the kinase domain and the negative
CC       autoregulatory C-terminal coiled-coil region. Agonist binding to
CC       the phorbol ester binding site disrupts this, releasing the kinase
CC       domain to allow N-terminus-mediated dimerization and kinase
CC       activation by transautophosphorylation.
CC   -!- SUBUNIT: Homodimer and homotetramer via the coiled coil regions.
CC       Interacts tightly with GTP-bound but not GDP-bound CDC42.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-689171, EBI-689171;
CC       P60953:CDC42; NbExp=3; IntAct=EBI-689171, EBI-81752;
CC       P17081:RHOQ; NbExp=1; IntAct=EBI-689171, EBI-689202;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Note=Displays a
CC       dispersed punctate distribution and concentrates along the cell
CC       periphery, especially at the leading edge and cell-cell junction.
CC       This concentration is PH-domain dependent (By similarity).
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q5VT25-1; Sequence=Displayed;
CC         Note=No experimental confirmation available;
CC       Name=2;
CC         IsoId=Q5VT25-2; Sequence=VSP_051861, VSP_051863;
CC         Note=No experimental confirmation available;
CC       Name=3;
CC         IsoId=Q5VT25-3; Sequence=VSP_051859, VSP_051860;
CC       Name=4;
CC         IsoId=Q5VT25-4; Sequence=VSP_051862;
CC         Note=No experimental confirmation available;
CC       Name=5;
CC         IsoId=Q5VT25-5; Sequence=VSP_051860;
CC       Name=6;
CC         IsoId=Q5VT25-6; Sequence=VSP_051860, VSP_035286;
CC   -!- TISSUE SPECIFICITY: Abundant in the heart, brain, skeletal muscle,
CC       kidney, and pancreas, with little or no expression in the lung and
CC       liver.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. DMPK subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 CNH domain.
CC   -!- SIMILARITY: Contains 1 CRIB domain.
CC   -!- SIMILARITY: Contains 1 PH domain.
CC   -!- SIMILARITY: Contains 1 phorbol-ester/DAG-type zinc finger.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92205.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ518975; CAD57745.1; -; mRNA.
DR   EMBL; AJ518976; CAD57746.1; -; mRNA.
DR   EMBL; AB208968; BAD92205.1; ALT_INIT; mRNA.
DR   EMBL; CR933723; CAI46252.1; -; mRNA.
DR   EMBL; AL353689; CAI19113.1; -; Genomic_DNA.
DR   EMBL; AL451047; CAH71184.1; -; Genomic_DNA.
DR   EMBL; AL353689; CAH71184.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAH71184.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAH71185.1; -; Genomic_DNA.
DR   EMBL; AL627308; CAH71185.1; JOINED; Genomic_DNA.
DR   EMBL; AL353689; CAH71185.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAH71336.1; -; Genomic_DNA.
DR   EMBL; AL353689; CAH71336.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAH71336.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAH71337.1; -; Genomic_DNA.
DR   EMBL; AL353689; CAH71337.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAH71337.1; JOINED; Genomic_DNA.
DR   EMBL; AL353689; CAI19108.1; -; Genomic_DNA.
DR   EMBL; AL451047; CAI19108.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAI19108.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAH71183.1; -; Genomic_DNA.
DR   EMBL; AL353689; CAH71183.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAH71183.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAH71338.1; -; Genomic_DNA.
DR   EMBL; AL353689; CAH71338.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAH71338.1; JOINED; Genomic_DNA.
DR   EMBL; AL353689; CAI19109.1; -; Genomic_DNA.
DR   EMBL; AL627308; CAI19109.1; JOINED; Genomic_DNA.
DR   EMBL; AL451047; CAI19109.1; JOINED; Genomic_DNA.
DR   EMBL; AL353689; CAI19110.1; -; Genomic_DNA.
DR   EMBL; AL451047; CAI19110.1; JOINED; Genomic_DNA.
DR   EMBL; AL627308; CAI19110.1; JOINED; Genomic_DNA.
DR   EMBL; AB007920; BAA32296.2; -; mRNA.
DR   EMBL; U59305; AAB37126.1; -; mRNA.
DR   IPI; IPI00550263; -.
DR   IPI; IPI00640468; -.
DR   IPI; IPI00640957; -.
DR   IPI; IPI00642165; -.
DR   IPI; IPI00654830; -.
DR   IPI; IPI00903296; -.
DR   RefSeq; NP_003598.2; -.
DR   RefSeq; NP_055641.3; -.
DR   UniGene; Hs.35433; -.
DR   ProteinModelPortal; Q5VT25; -.
DR   SMR; Q5VT25; 11-409, 879-940, 1009-1078, 1085-1205.
DR   IntAct; Q5VT25; 12.
DR   STRING; Q5VT25; -.
DR   PhosphoSite; Q5VT25; -.
DR   PRIDE; Q5VT25; -.
DR   Ensembl; ENST00000366765; ENSP00000355727; ENSG00000143776.
DR   GeneID; 8476; -.
DR   KEGG; hsa:8476; -.
DR   UCSC; uc001hqr.1; human.
DR   UCSC; uc001hqs.1; human.
DR   UCSC; uc009xes.1; human.
DR   CTD; 8476; -.
DR   GeneCards; GC01M227177; -.
DR   HGNC; HGNC:1737; CDC42BPA.
DR   MIM; 603412; gene.
DR   PharmGKB; PA26267; -.
DR   eggNOG; prNOG04641; -.
DR   HOVERGEN; HBG055933; -.
DR   OMA; GKVRHGA; -.
DR   PhylomeDB; Q5VT25; -.
DR   BRENDA; 2.7.11.1; 247.
DR   NextBio; 31715; -.
DR   ArrayExpress; Q5VT25; -.
DR   Bgee; Q5VT25; -.
DR   Genevestigator; Q5VT25; -.
DR   GermOnline; ENSG00000143776; Homo sapiens.
DR   GO; GO:0031252; C:cell leading edge; ISS:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0005083; F:small GTPase regulator activity; IEA:InterPro.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR001180; Citron.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR014930; Myotonic_dystrophy_kinase_coil.
DR   InterPro; IPR000095; PAK_box_Rho-bd.
DR   InterPro; IPR011993; PH_type.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR001849; Pleckstrin_homology.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   Gene3D; G3DSA:2.30.29.30; PH_type; 1.
DR   Pfam; PF00130; C1_1; 1.
DR   Pfam; PF00780; CNH; 1.
DR   Pfam; PF08826; DMPK_coil; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   ProDom; PD011252; Myotonic_dystrophy_kinase_coil; 1.
DR   SMART; SM00109; C1; 1.
DR   SMART; SM00036; CNH; 1.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50219; CNH; 1.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 1.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Coiled coil; Complete proteome;
KW   Cytoplasm; Kinase; Magnesium; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Serine/threonine-protein kinase;
KW   Transferase; Zinc; Zinc-finger.
FT   CHAIN         1   1732       Serine/threonine-protein kinase MRCK
FT                                alpha.
FT                                /FTId=PRO_0000086392.
FT   DOMAIN       77    343       Protein kinase.
FT   DOMAIN      344    414       AGC-kinase C-terminal.
FT   DOMAIN     1082   1201       PH.
FT   DOMAIN     1227   1499       CNH.
FT   DOMAIN     1571   1584       CRIB.
FT   NP_BIND      83     91       ATP (By similarity).
FT   ZN_FING    1012   1062       Phorbol-ester/DAG-type.
FT   COILED      437    820       Potential.
FT   COILED      880    943       Potential.
FT   ACT_SITE    201    201       Proton acceptor (By similarity).
FT   BINDING     106    106       ATP.
FT   MOD_RES     222    222       Phosphoserine; by autocatalysis.
FT   MOD_RES     234    234       Phosphoserine; by autocatalysis.
FT   MOD_RES     240    240       Phosphothreonine; by autocatalysis.
FT   MOD_RES    1545   1545       Phosphoserine.
FT   MOD_RES    1651   1651       Phosphoserine (By similarity).
FT   MOD_RES    1719   1719       Phosphoserine.
FT   MOD_RES    1721   1721       Phosphoserine.
FT   VAR_SEQ     550    630       Missing (in isoform 3).
FT                                /FTId=VSP_051859.
FT   VAR_SEQ     969   1009       Missing (in isoform 4).
FT                                /FTId=VSP_051862.
FT   VAR_SEQ     969    981       Missing (in isoform 3, isoform 5 and
FT                                isoform 6).
FT                                /FTId=VSP_051860.
FT   VAR_SEQ     969    969       R -> TDPVENTYVWNPSVKFHIQSRST (in isoform
FT                                2).
FT                                /FTId=VSP_051861.
FT   VAR_SEQ     973    981       CTPASKGRR -> TSSEAEPVK (in isoform 2).
FT                                /FTId=VSP_051863.
FT   VAR_SEQ    1597   1597       M -> MPGFPYPSPHHHSGLISSPINFEHIYHMTVNSAEKF
FT                                LSPDSINPEYSPSLRSVPGTPSFMTLR (in isoform
FT                                6).
FT                                /FTId=VSP_035286.
FT   VARIANT      50     50       E -> K (in a lung neuroendocrine
FT                                carcinoma sample; somatic mutation).
FT                                /FTId=VAR_040830.
FT   VARIANT     231    231       T -> M (in dbSNP:rs34614709).
FT                                /FTId=VAR_040831.
FT   VARIANT     537    537       I -> T (in dbSNP:rs56364976).
FT                                /FTId=VAR_040832.
FT   VARIANT     780    780       T -> M (in dbSNP:rs56119119).
FT                                /FTId=VAR_045583.
FT   VARIANT     790    790       Y -> C (in dbSNP:rs34943764).
FT                                /FTId=VAR_045584.
FT   VARIANT    1148   1148       A -> T.
FT                                /FTId=VAR_045585.
FT   VARIANT    1211   1211       R -> H.
FT                                /FTId=VAR_045586.
FT   VARIANT    1317   1317       V -> I.
FT                                /FTId=VAR_045587.
FT   VARIANT    1418   1418       I -> K.
FT                                /FTId=VAR_040833.
FT   VARIANT    1469   1469       A -> V (in dbSNP:rs55687355).
FT                                /FTId=VAR_045588.
FT   VARIANT    1618   1618       T -> A.
FT                                /FTId=VAR_045589.
FT   VARIANT    1699   1699       A -> V (in dbSNP:rs2802269).
FT                                /FTId=VAR_045590.
FT   VARIANT    1712   1712       A -> V (in dbSNP:rs2802269).
FT                                /FTId=VAR_057104.
FT   MUTAGEN     106    106       K->A: Loss of kinase activity.
FT   MUTAGEN     222    222       S->L: Increase in autophosphorylation but
FT                                not kinase activity.
FT   MUTAGEN     234    234       S->A: Loss of autophosphorylation and
FT                                kinase activity.
FT   MUTAGEN     240    240       T->A: Loss of autophosphorylation and
FT                                kinase activity.
FT   MUTAGEN     403    403       T->A: Loss of autophosphorylation and
FT                                kinase activity.
FT   MUTAGEN    1579   1579       H->A: Loss of CDC42 binding; when
FT                                associated with A-1582.
FT   MUTAGEN    1582   1582       H->A: Loss of CDC42 binding; when
FT                                associated with A-1579.
FT   CONFLICT     25     25       C -> Y (in Ref. 5; AAB37126).
FT   CONFLICT    809    809       D -> N (in Ref. 3; CAI46252).
FT   CONFLICT   1521   1521       L -> V (in Ref. 8).
FT   CONFLICT   1688   1688       G -> K (in Ref. 6; BAA32296).
SQ   SEQUENCE   1732 AA;  197307 MW;  48B10F81B5405A0A CRC64;
     MSGEVRLRQL EQFILDGPAQ TNGQCFSVET LLDILICLYD ECNNSPLRRE KNILEYLEWA
     KPFTSKVKQM RLHREDFEIL KVIGRGAFGE VAVVKLKNAD KVFAMKILNK WEMLKRAETA
     CFREERDVLV NGDNKWITTL HYAFQDDNNL YLVMDYYVGG DLLTLLSKFE DRLPEDMARF
     YLAEMVIAID SVHQLHYVHR DIKPDNILMD MNGHIRLADF GSCLKLMEDG TVQSSVAVGT
     PDYISPEILQ AMEDGKGRYG PECDWWSLGV CMYEMLYGET PFYAESLVET YGKIMNHKER
     FQFPAQVTDV SENAKDLIRR LICSREHRLG QNGIEDFKKH PFFSGIDWDN IRNCEAPYIP
     EVSSPTDTSN FDVDDDCLKN SETMPPPTHT AFSGHHLPFV GFTYTSSCVL SDRSCLRVTA
     GPTSLDLDVN VQRTLDNNLA TEAYERRIKR LEQEKLELSR KLQESTQTVQ ALQYSTVDGP
     LTASKDLEIK NLKEEIEKLR KQVTESSHLE QQLEEANAVR QELDDAFRQI KAYEKQIKTL
     QQEREDLNKE LVQASERLKN QSKELKDAHC QRKLAMQEFM EINERLTELH TQKQKLARHV
     RDKEEEVDLV MQKVESLRQE LRRTERAKKE LEVHTEALAA EASKDRKLRE QSEHYSKQLE
     NELEGLKQKQ ISYSPGVCSI EHQQEITKLK TDLEKKSIFY EEELSKREGI HANEIKNLKK
     ELHDSEGQQL ALNKEIMILK DKLEKTRRES QSEREEFESE FKQQYEREKV LLTEENKKLT
     SELDKLTTLY ENLSIHNQQL EEEVKDLADK KESVAHWEAQ ITEIIQWVSD EKDARGYLQA
     LASKMTEELE ALRNSSLGTR ATDMPWKMRR FAKLDMSARL ELQSALDAEI RAKQAIQEEL
     NKVKASNIIT ECKLKDSEKK NLELLSEIEQ LIKDTEELRS EKGIEHQDSQ HSFLAFLNTP
     TDALDQFERS PSCTPASKGR RTVDSTPLSV HTPTLRKKGC PGSTGFPPKR KTHQFFVKSF
     TTPTKCHQCT SLMVGLIRQG CSCEVCGFSC HITCVNKAPT TCPVPPEQTK GPLGIDPQKG
     IGTAYEGHVR IPKPAGVKKG WQRALAIVCD FKLFLYDIAE GKASQPSVVI SQVIDMRDEE
     FSVSSVLASD VIHASRKDIP CIFRVTASQL SASNNKCSIL MLADTENEKN KWVGVLSELH
     KILKKNKFRD RSVYVPKEAY DSTLPLIKTT QAAAIIDHER IALGNEEGLF VVHVTKDEII
     RVGDNKKIHQ IELIPNDQLV AVISGRNRHV RLFPMSALDG RETDFYKLSE TKGCQTVTSG
     KVRHGALTCL CVAMKRQVLC YELFQSKTRH RKFKEIQVPY NVQWMAIFSE QLCVGFQSGF
     LRYPLNGEGN PYSMLHSNDH TLSFIAHQPM DAICAVEISS KEYLLCFNSI GIYTDCQGRR
     SRQQELMWPA NPSSCCYNAP YLSVYSENAV DIFDVNSMEW IQTLPLKKVR PLNNEGSLNL
     LGLETIRLIY FKNKMAEGDE LVVPETSDNS RKQMVRNINN KRRYSFRVPE EERMQQRREM
     LRDPEMRNKL ISNPTNFNHI AHMGPGDGIQ ILKDLPMNPR PQESRTVFSG SVSIPSITKS
     RPEPGRSMSA SSGLSARSSA QNGSALKREF SGGSYSAKRQ PMPSPSEGSL SSGGMDQGSD
     APARDFDGED SDSPRHSTAS NSSNLSSPPS PASPRKTKSL SLESTDRGSW DP
//
